Zheng Quan Shi Bao·2025-11-06 10:41Core Viewpoint - The news highlights significant developments in Chongqing, including administrative district adjustments and initiatives to support the high-quality development of innovative pharmaceuticals, which have led to a surge in local stock prices. Administrative District Adjustments - On November 6, Chongqing announced administrative district adjustments affecting the Liangjiang New Area, Jiangbei District, Yubei District, and Beibei District, aiming to optimize urban spatial structure and functionality [5][6] - The first major adjustment involves the establishment of Liangjiang New Area by merging Jiangbei and Yubei Districts, enhancing urban integration and promoting coordinated development [7] - The second adjustment transfers five towns from Yubei District to Beibei District, focusing on ecological and cultural resource integration to foster new development paths [8] Innovative Pharmaceutical Development - Chongqing's government issued measures to support the high-quality development of innovative pharmaceuticals, aiming to approve 1-3 new drugs annually by 2027 and establish three innovation industry complexes [10] - Financial support for innovative drug research includes up to 20% of total R&D costs, with maximum funding of 200 million yuan for early-stage trials and 1 billion yuan for late-stage trials [12] - The measures also promote the establishment of R&D service platforms and encourage the use of artificial intelligence in drug development, aiming to create a comprehensive AI-driven pharmaceutical innovation ecosystem [13][14]